Yayınlar & Eserler

Yayın Ağı
Makaleler 31
Tümü (31)
SCI-E, SSCI, AHCI (29)
SCI-E, SSCI, AHCI, ESCI (31)
ESCI (2)
Scopus (31)

1. Preoperative CT-based node-RADS scoring for risk stratification in pancreatic head cancer: diagnostic accuracy and survival implications

Parlatan C., Turunç Ş. G., DİLEK O., Özdemir G., ÇİL T.
European Journal of Radiology , cilt.201, 2026 (SCI-Expanded, Scopus)

2. PARP and Androgen-Signaling Inhibition plus ADT in Metastatic Prostate Cancer

Agarwal N., Matsubara N., Azad A. A., Saad F., Mateo J., Jiang S., et al.
The New England journal of medicine , cilt.395, sa.5, ss.427-439, 2026 (SCI-Expanded, Scopus)

3. MRI Dark–Light–Dark Sign and Node Reporting Score: An Integrated Model for Predicting Lymph Node Metastasis in Rectal Cancer

Parlatan C., Turunç Ş. G., DİLEK O., Taş Z. A., Özdemir G., ÇİL T.
Journal of Clinical Medicine , cilt.15, sa.13, 2026 (SCI-Expanded, Scopus)

4. Brigatinib-associated autoimmune hepatitis: A case report

BÜYÜKŞİMŞEK M., Ogul A., Yetisir A. E., BOZKURT DUMAN B., TOHUMCUOĞLU M., ÇİL T., et al.
Journal of Oncology Pharmacy Practice , cilt.32, sa.4, ss.754-756, 2026 (SCI-Expanded, Scopus)

5. Prevalence and Reactivation of Hepatitis B and C in Patients Undergoing Chemotherapy for Solid Tumors

Gürbüz M., Tural D., ÇİL T., Demir H., KÖSTEK O., SEVER Ö. N., et al.
JCO Global Oncology , cilt.12, 2026 (ESCI, Scopus)

6. Amivantamab plus chemotherapy versus chemotherapy for first-line treatment of participants with EGFR exon 20 insertion-mutated advanced non-small cell lung cancer: PAPILLON Asia subgroup analysis

Zhou C., Tang K., Liu B., Kim S., Kitazono S., Ono A., et al.
Lung Cancer , cilt.213, 2026 (SCI-Expanded, Scopus)

7. Baseline ALBI Grade as an Independent Prognostic Factor of Survival in High-Risk Real-World HCC Under Atezolizumab–Bevacizumab

Araz F., Köse F., ÇİL T., BOZKURT DUMAN B., Arslan Benli B., Karadeli E., et al.
Journal of Hepatocellular Carcinoma , cilt.13, 2026 (SCI-Expanded, Scopus) Creative Commons License

8. Prognostic and diagnostic value of node-RADS before and after neoadjuvant therapy in locally advanced gastric cancer

DİLEK O., Demirel E., Erisen K. K., Ulas Z. O., Turunc S. G., Tas Z. A., et al.
European Journal of Radiology , cilt.194, 2026 (SCI-Expanded, Scopus)

9. The impact of carboplatin on pathologic complete response and survival based on HER2 low and HER2 zero status in triple negative breast cancer patients receiving neoadjuvant chemotherapy: a multicenter real-world analysis

Yıldırım S., Başoğlu T., Doğan A., Akdağ G., Kınıkoğlu O., Topal A., et al.
BMC Cancer , cilt.25, sa.1, 2025 (SCI-Expanded, Scopus)

10. Retifanlimab versus placebo in combination with platinum-based chemotherapy in patients with first-line non-squamous or squamous metastatic non-small-cell lung cancer (POD1UM-304): a phase 3, multiregional, placebo-controlled, double-blind, randomised study

Lu S., Vynnychenko O., Kulyaba Y., Kuchava V., Ibrahim A., Moiseenko F., et al.
The Lancet Respiratory Medicine , cilt.13, sa.12, ss.1096-1107, 2025 (SCI-Expanded, Scopus)

11. Radiologic Follow-up of Vascular Structures in Gastric Cancer Patients Receiving Adjuvant Radiotherapy

Karaca F., Keskin S., Akkaya H., Menteş S., Altintas S., Bayhan A., et al.
Nigerian Journal of Clinical Practice , cilt.28, sa.7, ss.848-853, 2025 (SCI-Expanded, Scopus)

12. Evaluation of the efficacy of regorafenib treatment by location and RAS mutation in metastatic colon cancer

Ata S., Gülmez A., KÖŞECİ T., ÖZALP Ö., ÇİL T., BOZKURT DUMAN B.
Medicine (United States) , cilt.104, sa.26, 2025 (SCI-Expanded, Scopus)

13. The frequency of driver mutations in non-small cell lung cancer patients: The Turkish nation-wide, observational, Registurk-Lung study (updated analysis).

TURAN N., ÇİL T., Artac M., Hacibekiroglu I., Sümbül A. T., Uncu D., et al.
Journal of Clinical Oncology , cilt.43, 2025 (SCI-Expanded, Scopus)

14. The prognostic value of halp score in predicting the efficacy of nivolumab treatment in metastatic malignant melanoma patients: A real-life, retrospective, single center analysis

Ata S., KÖŞECİ T., Benli B. A., Bayhan A. Z., KESEN O., Solmaz A. A., et al.
Medicine (United States) , cilt.104, sa.18, 2025 (SCI-Expanded, Scopus)

15. Real-world treatment outcomes from nationwide Onco-colon Turkey registry in RAS wild-type patients treated with biologics second-line mCRC

Yildirim M. E., KARADURMUŞ N., Ökten İ. N., TÜRK H. M., Urakçı Z., Arslan Ç., et al.
Journal of Oncology Pharmacy Practice , cilt.31, sa.3, ss.404-411, 2025 (SCI-Expanded, Scopus)

16. Prognostic Significance of the Combined Albumin-To-Alkaline Phosphatase Ratio (AAPR) and Haemoglobin–Albumin–Lymphocyte–Platelet (HALP) Score in Patients with Metastatic Renal Cell Carcinoma Treated by Targeted Therapy: A New Prognostic Combined Risk Scoring

KÖŞECİ T., Seyyar M., Kıdı M. M., Biter S., Eser K., KEFELİ U., et al.
Journal of Clinical Medicine , cilt.14, sa.5, 2025 (SCI-Expanded, Scopus)

17. Nivolumab plus ipilimumab versus nivolumab in microsatellite instability-high metastatic colorectal cancer (CheckMate 8HW): a randomised, open-label, phase 3 trial

André T., Elez E., Lenz H., Jensen L. H., Touchefeu Y., Van Cutsem E., et al.
The Lancet , cilt.405, sa.10476, ss.383-395, 2025 (SCI-Expanded, Scopus)

18. Dynamics of body composition in the treatment of locally advanced rectal cancer: the ımpact of adipose and muscle tissue on pathological response

DİLEK O., Demırel E., Eyı B., Turunc S. G., Akkaya H., Tas Z. A., et al.
Revista da Associacao Medica Brasileira , cilt.71, sa.10, 2025 (SCI-Expanded, Scopus)

19. Importance of 18F-fluorodeoxyglucose positron emission tomography/computed tomography heterogeneity indices in non-small cell lung cancer

Ogul A., Birsenogul I., Kelle A. P., Solmaz A. A., Coskun Y., Yetisir A. E., et al.
Revista da Associacao Medica Brasileira , cilt.71, sa.5, 2025 (SCI-Expanded, Scopus)

20. Sequential Use of Sorafenib and Regorafenib in Hepatocellular Cancer Recurrence After Liver Transplantation: Treatment Strategies and Outcomes

Ozbay M. F., HARPUTLUOĞLU H., KARACA M., Tekin O., Şendur M. A. N., Kaplan M. A., et al.
Cancers , cilt.16, sa.22, 2024 (SCI-Expanded, Scopus)

21. The impact of tamoxifen treatment on voice parameters in premenopausal women with breast cancer

Ata S., Ekici N. Y., BÜYÜKŞİMŞEK M., ÇİL T., BOZKURT DUMAN B.
European Archives of Oto-Rhino-Laryngology , cilt.281, sa.2, ss.1025-1030, 2024 (SCI-Expanded, Scopus)

22. Enteral nutrition consensus report from KEPAN: Indications, choice, practical application, and follow-up

DOĞANAY M., Akcay K., ÇİL T., Dag B., Demirag K., Demirkan K., et al.
Nutrition , cilt.118, 2024 (SCI-Expanded, Scopus)

23. Optimal use of oral nutritional supplements (ONS) in medical nutrition therapy: ONS consensus report from KEPAN

BAHAT-ÖZTÜRK G., Bahat G., Akmansu M., Akmansu M., Güngör İ. L., Gungor L., et al.
European Journal of Clinical Nutrition , cilt.77, sa.7, ss.705-709, 2023 (SCI-Expanded, Scopus) Creative Commons License

24. Panitumumab Associated Acute Pancreatitis

Arbag H. C., SÜMBÜL H. E., BÜYÜKŞİMŞEK M., Ogul A., Yetisir A. E., Koseci T., et al.
Journal of Oncology Pharmacy Practice , cilt.28, sa.5, ss.1207-1208, 2022 (SCI-Expanded, Scopus)

25. Prognostic Importance of Inflammatory Indexes in Patients Treated by Pazopanib for Soft Tissue Sarcoma

Koseci T., Haksoyler V., Olgun P., Ata S., Nayir E., BOZKURT DUMAN B., et al.
Clinical Laboratory , cilt.68, sa.2, ss.340-352, 2022 (SCI-Expanded, Scopus)

26. Do the Survival Data of Primary Tumor Resection Provide Sufficient Data Without Considering the Tumor Sidedness, Predictive Biomarkers, and Biologic Agents?

BOZKURT DUMAN B., ÇİL T.
Journal of Clinical Oncology , cilt.39, sa.26, ss.2970, 2021 (SCI-Expanded, Scopus)

27. Comparison of MRI findings of glioblastoma and gliosarcoma – can conventional MRI provide beneficial differences for diagnosis? Porovnání nálezů MR u glioblastomu a gliosarkomu – mohou být při konvenční MR odhaleny diagnostické rozdíly?

KAYA Ö., DİLEK O., Koseci T., ÇİL T., YILMAZ C., GÜLEK B.
Ceska a Slovenska Neurologie a Neurochirurgie , cilt.84, sa.3, ss.251-256, 2021 (SCI-Expanded, Scopus)

28. Systemic treatment in bone metastases

KESEN O., ÇİL T.
Turk Onkoloji Dergisi , cilt.36, ss.33-37, 2021 (ESCI, Scopus) Creative Commons License

29. Predictors of Survival in Turkish Patients with Primary Glioblastoma

BİLGİN E., BOZKURT DUMAN B., Altintas S., ÇİL T., GEZERCAN Y., ÖKTEN A. İ.
Turkish Neurosurgery , cilt.31, sa.4, ss.641-653, 2021 (SCI-Expanded, Scopus)

30. Steatohepatitis due to FOLFIRINOX regimen in adjuvant pancreas cancer treatment mimicking liver metastasis

BOZKURT DUMAN B., ÇİL T.
Journal of Oncology Pharmacy Practice , cilt.26, sa.7, ss.1738-1742, 2020 (SCI-Expanded, Scopus)

31. Pertuzumab, trastuzumab and taxane-based treatment for visceral organ metastatic, trastuzumab-naïve breast cancer: real-life practice outcomes

Esin E., Oksuzoglu B., BİLİCİ A., Cicin I., KÖSTEK O., Kaplan M., et al.
Cancer Chemotherapy and Pharmacology , cilt.83, sa.1, ss.131-143, 2019 (SCI-Expanded, Scopus)
Metrikler

Yayın

31

Yayın (WoS)

31

Yayın (Scopus)

31

H-İndeks (WoS)

5

Atıf (Scopus)

296

H-İndeks (Scopus)

6

Proje

1

Tez Danışmanlığı

6

Açık Erişim

8